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abuse, and increasing risk of HIV and other sexually trans-
mitted infections. Lack of postwar shelter compounds
other problems and increases exposure to mosquitoborne
diseases. Lack of clean drinking water introduces risks of
bacillary dysentery, cholera, diarrheal disease, typhoid,
hepatitis A, and other diseases. 
Researchers concluded that solutions to the negative
impact of war on women's health should be based in edu-
cation, empowerment, efficient publicity, and effective
policies. A sub-ministry devoted to women's affairs and
maternal and child health was recommended, with funding
specifically earmarked for women's health. Regular
screening for preventable or treatable disease should be
done in the home country and continued after the safety
period ends.
Violations of International Women’s Rights:
Effects on the Overall Health of Women
Findings from a study by Physicians for Human Rights
indicate that nearly half of all households in three southern
cities in Iraq experienced human rights abuses among
household members between 1991 and 2003. Such abuses
represent considerable challenges for justice and account-
ability and emphasize the need to address individual and
community mental health needs on a large scale. The
prevalence of mental illness represents a challenge to the
Iraqi health system, since <100 psychiatrists are reported
to practice in the country, and therapeutic medications and
social support systems are lacking. 
Households surveyed expressed support for a govern-
ment that would protect and promote human rights, includ-
ing the rights of women. However, the lack of support for
certain women’s rights by both men and women may make
the full range of women's human rights difficult to achieve.
Consequently, restrictions on women’s rights or ineffective
representation of women may have substantial, adverse
health consequences for women and girls. This study sug-
gests the need for a gender- and rights-based approach for
reconstruction and community health and development in
Iraq. 
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Prevention of Hepatitis C 
in Women
Hepatitis C is a major public health problem in the
United States. Although the incidence of new infections
declined substantially in the past decade, approximately
25,000 persons are infected each year. In total, an estimat-
ed 2.7 million Americans have chronic hepatitis C virus
(HCV) infection and are at risk for HCV-related chronic
liver disease and hepatocellular carcinoma (HCC). 
The most common exposure associated with HCV
infection is use of injection drugs. Other less commonly
identified risk factors include sexual contact; transfusions
before blood screening was implemented; and occupation-
al, nosocomial, and perinatal exposures. Although sources
of HCV infection are the same for men and women, the
overall prevalence of HCV infection is lower among
women than men, which is likely related to the lower
prevalence of injection-drug use among women.
The risk for HCV transmission from mother to infant is
about 5%–6%; transmission occurs only from women who
are HCV RNA positive and is higher among those coin-
fected with HIV (≈18.7%) than among women not infect-
ed with HIV (≈5.4%). The influence of factors such as
maternal viral titer and interventions at the time of deliv-
ery is unclear. Studies indicate that breastfeeding is not a
risk factor for perinatal transmission.
Most hepatitis C prevention strategies are gender neu-
tral and include screening and testing donors of blood,
plasma, organ, tissue, and semen; virus inactivation of
plasma-derived products; effective infection control prac-
tices; identification, counseling, and testing of at-risk per-
sons; and medical management of infected persons.
Pregnant women with risk factors for infection should be
identified, screened, and counseled regarding the risk for
perinatal transmission.
Clinical Reports
Although risk factors for HCV acquisition are similar
among men and women, women are at higher risk of
acquiring HCV from sexual contact with an HCV-infected
partner and more likely to be initiated into drug use, share
needles, or be injected by a sexual partner. Among HCV-
infected women, pregnancy may lead to worsening of his-
tologic disease. Other gender differences in the natural
history of hepatitis C are that the rate of spontaneous HCV
clearance may be higher among women than men, the risk
for fibrosis progression and HCC are lower in women than
men, and alcohol use by women with hepatitis C is likely
to have more pronounced negative effects on the liver than
is observed among HCV-infected men. There do not
appear to be substantial gender differences in response to
currently available therapy. 
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Approximately 2.2% of the world’s population, 130
million people, are infected with HCV. Worldwide, an esti-
mated 325,000 deaths from HCV-attributable HCC and
cirrhosis occur annually. In industrialized countries, most
HCV-infected persons have prevalent, chronic infections,
attributable to past exposures such as injection drug use,
blood transfusions, and sexual contact. Primary prevention
strategies include reducing harm and preventing nosoco-
mial transmission. In developing countries, many incident,
new infections are due to health care-related exposures
such as unsafe injections, and prevention strategies focus
on safe health care as well as reducing harm.
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